Injectable, extended-release buprenorphine was deemed safe for patients experiencing minimal to mild opioid withdrawal (COWS scores 4-7), making the drug a viable and safe treatment option, according ...
Researchers conducted a literature search to identify whether buprenorphine initiation in the emergency department would reduce mortality rates in patients suspected of opioid withdrawal. DENVER — ...
Clinically and statistically significant improvements were observed in Clinical Opiate Withdrawal Scale (COWS), Subjective Opiate Withdrawal Scale (SOWS), and opioid cravings VAS (Visual Analogue ...
Please provide your email address to receive an email when new articles are posted on . Precipitated withdrawal occurred among less than 1% of patients despite a high prevalence of fentanyl use. The ...
Among 100 adult patients with minimal-to-mild opioid withdrawal scores who were given a 24-mg dose of extended-release buprenorphine, only 10 people (10%, 95% CI 4.9% ...
Third-party research groups and organizations have validated a smartphone app called Reflex as a tool to help diagnose medical conditions like concussions and opiate withdrawal. Brightlamp CEO Kurtis ...
DALLAS & COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle, the largest independent nonprofit applied science and technology organization in the world, and Spark Biomedical, Inc., a leading developer of ...
MIAMI — Lofexidine (Lucemyra, US Worldmeds), which has been in use in the United Kingdom for more than 20 years, is now available in the United States. The drug is used in the management of symptoms ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback